ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Somatostatin Receptor Imaging with ¹¹¹In-Pentetreotide

scintigraphy with 111 In-pentetreotide, published by the Society of Nuclear Medicine 99m Tc-Depreotide (Neotect ) is another commercially available somatostatin analog that has been approved specifically for the detection of lung cancer in patients with pulmonary nodules Because of the relatively high abdominal background and the impossibility of performing delayed imaging due to the short half-life of the tracer, it is less suited for the detection of abdominal neuroendocrine tumors